Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: A rationale for new treatment strategies

Ophthalmology

Volumn 109, Issue 10, 2002, Pages 1765-1766

  Jampol, Lee M ^a   Weinreb, Robert ^a   Yannuzzi, Lawrence ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOSTEROID; CORTICOSTEROID ANTAGONIST; KETOCONAZOLE; MIFEPRISTONE;

CHORIORETINOPATHY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG COST; DRUG MECHANISM; EDITORIAL; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETINA DETACHMENT; RISK FACTOR;

EID: 0036789478     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01303-9     Document Type: Article

References (31)

1. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984;91:1554-72.
2. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984;68:329-31.
3. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-8.
4. Gass JDM, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995;102:737-47.
5. Thoelen AM, Bernasconi PP, Schmid C, Messmer EP. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina 2000;20:98-9.
6. Zamir E. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and hypothesis. Graefes Arch Clin Exp Ophthalmol 1997;235:339-44.
7. Haimovici R, Gradoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997;104:1653-60.
8. Kao LY. Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection. Retina 1998;18:479-81.
9. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002;109:1834-7.
10. Beato M, Chavez S, Truss M. Transcriptional regulation by steroid hormones. Steroids 1996;61:240-51.
11. Beato M, Klug J. Steroid hormone receptors: an update. Hum Reprod Update 2000;6:225-36.
12. Falkenstein E, Norman AW, Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab 2000;85:2072-5.
13. Makara GB, Haller J. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 2001;65:367-90.
14. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the α1B adrenergic receptor gene in DTTI MF-2 smooth muscle cells. J Clin Invest 1991;88:385-9.
15. Hadcock JR, Malbon CC. Regulation of β-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA 1988;85:8415-9.
16. Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina 1987;7:111-31.
17. Hassan L, Carvalho C, Yannuzzi LA, et al. Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or "ecstasy." Retina 2001;21:559-61.
18. Nagayoshi K. Experimental study of chorioretinopathy by intravenous injection of adrenaline. Nippon Ganka Gakkai Zasshi 1971;75:1720-7.
19. Miki T, Sunada I, Higaki T. Studies on chorioretinitis induced in rabbits by stress (repeted administration of epinephrine). Nippon Ganka Gakkai Zasshi 1972;76:1037-45.
20. Yoshioka H, Sugita T, Nagayoshi K. Fluorescein angiographic findings in experimental retinopathy produced by intravenous adrenaline injection. Preliminary report. Nippon Ganka Kiyo 1970;21:648-52.
21. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica 1982;185:168-78.
22. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-62.
23. Prunte C, Flammer J. Choriodal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
24. Giovannini A, Scassellati-Sforzolini B, D'Altobrando E, et al. Choroidal findings in the course of idiopathic serous pigment epithelial detachment detected by indocyanine green videoangiography. Retina 1997;17:286-93.
25. Frambach DA, Fain GL, Farber DB, Bok D. Beta adrenergic receptors on cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1990;31:1767-72.
26. Walker BR, Best R, Shackleton CHL, et al. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996;27:190-6.
27. Garg SP, Dada T, Talwar D, Biswas NR. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997;81:962-4.
28. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993; 111: 1229-33.
29. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy (submitted to Ophthalmology).
30. Beck CA, Estes PA, Bona BJ, et al. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology 1993;133:728-40.
31. Cadepond F, Ulmann A, Baulieu EE. RU 486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997;48:129-56.